Unknown

Dataset Information

0

SMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1? signaling pathways.


ABSTRACT: The suppressor of MEK null (sMEK1) protein possesses pro-apoptotic activities. In the current study, we reveal that sMEK1 functions as a novel anti-angiogenic factor by suppressing vascular endothelial growth factor (VEGF)-induced cell proliferation, migration, and capillary-like tubular structure in vitro. In addition, sMEK1 inhibited the phosphorylation of the signaling components up- and downstream of Akt, including phospholipase C?1 (PLC-?1), 3-phosphoinositide-dependent protein kinase 1 (PDK1), endothelial nitric oxide synthetase (eNOS), and hypoxia-inducible factor 1 (HIF-1?) during ovarian tumor progression via binding with vascular endothelial growth factor receptor 2 (VEGFR-2). Furthermore, sMEK1 decreased tumor vascularity and inhibited tumor growth in a xenograft human ovarian tumor model. These results supply convincing evidence that sMEK1 controls endothelial cell function and subsequent angiogenesis by suppressing VEGFR-2-mediated PI3K/Akt/eNOS signaling pathway. Taken together, our results clearly suggest that sMEK1 might be a novel anti-angiogenic and anti-tumor agent for use in ovarian tumor.

SUBMITTER: Kim BR 

PROVIDER: S-EPMC4741643 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.

Kim Boh-Ram BR   Seo Seung Hee SH   Park Mi Sun MS   Lee Seung-Hoon SH   Kwon Youngjoo Y   Rho Seung Bae SB  

Oncotarget 20151001 31


The suppressor of MEK null (sMEK1) protein possesses pro-apoptotic activities. In the current study, we reveal that sMEK1 functions as a novel anti-angiogenic factor by suppressing vascular endothelial growth factor (VEGF)-induced cell proliferation, migration, and capillary-like tubular structure in vitro. In addition, sMEK1 inhibited the phosphorylation of the signaling components up- and downstream of Akt, including phospholipase Cγ1 (PLC-γ1), 3-phosphoinositide-dependent protein kinase 1 (PD  ...[more]

Similar Datasets

| S-EPMC3743752 | biostudies-literature
| S-EPMC2933231 | biostudies-literature
| S-EPMC3232289 | biostudies-literature
| S-EPMC3416768 | biostudies-literature
| S-EPMC9274736 | biostudies-literature
| S-EPMC7753898 | biostudies-literature
| S-EPMC7997661 | biostudies-literature
| S-EPMC4440044 | biostudies-literature
| S-EPMC4057725 | biostudies-literature
| S-EPMC8365603 | biostudies-literature